NovoCure Ltd - Company Profile
Powered by 
All the data and insights you need on NovoCure Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date NovoCure Ltd Strategy Report
- Understand NovoCure Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on NovoCure Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into NovoCure Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
William F. Doyle
Chairman Executive BoardMr. William F. Doyle has been the Executive Chairman of NovoCure since 2016. He has been a member of the Board of Directors of the company since 2004. Mr. Doyle also serves as the Managing Director at WFD Ventures LLC from 2002; member of Johnson & Johnson's Medical Devices and Diagnostics Group Operating Committee; and as the Vice President of Licensing and Acquisitions from 1995 to 1999. While at Johnson & Johnson, Mr. Doyle also served as the Chairman of the Medical Devices Research and Development Council, Worldwide President at Biosense-Webster Inc, and a Member of the Board of Directors of Johnson & Johnson Development Corp and Cordis Corp. He worked as a Consultant at McKinsey & Co from 1992 to 1995.
Asaf Danziger
Chief Executive Officer; Director Executive BoardMr. Asaf Danziger has been the Chief Executive Officer and Direcor of NovoCure since 2012. Prior to this, he served as the Chief Executive Officer of Cybro Medical since from 1998 to 2002.
Ashley Cordova
Chief Financial Officer Senior ManagementMs. Ashley Cordova serves as Chief Financial Officer of the company since September 2020. Prior to this, she served in various positions at the company since 2014, including Senior Vice President, Finance and Investor Relations, Director of Global Treasury, Senior Director, Investor Relations and Global Treasury, and Vice President, Finance and Investor Relations. She has also worked with Zoetis Inc from 2012 to 2014 and Pfizer Inc from 2005 to 2012.
Wilhelmus Groenhuysen
Chief Operating Officer Senior ManagementMr. Wilhelmus Groenhuysen has been the Chief Operating Officer of the company since 2020. Prior to this, he has been the Chief Financial Officer of the company since 2012. He has served on the Board of Optinose Inc since October 2017. He also served as the Executive Vice President and Chief Financial Officer of Cephalon Inc from 2007 to 2011; and as the Chief Financial Officer and Senior Vice President of Philips Electronics North America Corporation.
Nicolas Leupin, M.D., Ph.D., MBA
Chief Medical Officer Senior ManagementDr. Nicolas Leupin has been the Chief Medical Officer of the company since 2024. Previously, he served as Chief Medical Officer at Molecular Partners. Before his role at Molecular Partners, he served as the Chief Medical Officer at Argenx.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer